Edition:
United Kingdom

People: Boston Scientific Corp (BSX.N)

BSX.N on New York Stock Exchange

42.25USD
9:01pm BST
Change (% chg)

$-0.39 (-0.91%)
Prev Close
$42.64
Open
$42.85
Day's High
$42.95
Day's Low
$42.17
Volume
2,657,305
Avg. Vol
1,964,930
52-wk High
$43.65
52-wk Low
$31.57

Brennan, Daniel 

Mr. Daniel J. Brennan is Chief Financial Officer, Executive Vice President of the Company. he is our executive vice president and chief financial officer, a position he has held since January 2014. In this role, he is responsible for several company functions, including Global Controllership, Global Internal Audit, Corporate Finance, Treasury, Corporate Tax, Investor Relations, and Corporate Business Development. Prior to that, he was the Company's senior vice president and corporate controller, a role he served in since January 2010. Since joining Boston Scientific in December 1996, Mr. Brennan has held roles with increased responsibilities, including vice president and assistant corporate controller, vice president of Finance and Information Technology for Worldwide Financial & Strategic Planning, Investor Relations, International Finance and Cardiovascular, group controller of the non-vascular business and controller of the Meditech Vascular business. He holds a B.S. degree in Finance and Investments and an M.B.A from Babson College. Mr. Brennan is also a certified public accountant and a member of the board of overseers of Babson College. He currently is a member of the Board of Directors of Nuance Communications.

Basic Compensation

Total Annual Compensation, USD 1,248,370
Restricted Stock Award, USD 1,719,880
Long-Term Incentive Plans, USD --
All Other, USD 697,570
Fiscal Year Total, USD 3,665,820

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised 60,209 1,164,550.00
Name Fiscal Year Total

Michael Mahoney

13,970,900

Daniel Brennan

3,665,820

Kevin Ballinger

2,841,490

Joseph Fitzgerald

4,036,320

Edward Mackey

3,818,020

Ian Meredith

--
As Of  31 Dec 2018